Skip to main content

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutritional Epidemiology

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1532080

Association of plasma zinc and copper levels with mild cognitive impairment in patients with type 2 diabetes

Provisionally accepted
Yang Jiao Yang Jiao Xing Zhang Xing Zhang Lian Duan Lian Duan Ruijie Cheng Ruijie Cheng Ning Yang Ning Yang Zhao Peng Zhao Peng Ben Li Ben Li Lu Xu Lu Xu Wenwen Chen Wenwen Chen Jingrong Chen Jingrong Chen Yanchao Liu Yanchao Liu *Hong Yan Hong Yan *
  • Huazhong University of Science and Technology, Wuhan, China

The final, formatted version of the article will be published soon.

    Background Type 2 diabetes mellitus (T2DM) is a significant risk factor for cognitive impairment. Zinc deficiency contributes to T2DM development, while copper may exacerbate diabetes through prooxidant mechanisms. Higher zinc levels may protect against copper toxicity. This study investigates the association of plasma zinc and copper levels with mild cognitive impairment (MCI) in T2DM patients.Methods T2DM patients admitted to Tongji Hospital from 2012 to 2018 were classified into MCI (n=136) and control (n=136) groups, matched by age (± 3 years) and gender. Conditional logistic regression was used to assess the associations between plasma zinc, copper levels and MCI. A generalized additive model (GAM) evaluated the dose-response relationship between plasma zinc, copper levels and Mini-Mental State Examination (MMSE) scores.The median of plasma metal levels in MCI and control groups were 831.31 μg/L and 936.29 μg/L for zinc, 932.07 μg/L and 860.47 μg/L for copper, and 0.91 and 1.11 for the zinc-to-copper (Zn/Cu) ratio. Compared to participants in the lowest tertile, the multivariable-adjusted odds ratios with 95% confidence intervals (CI) for MCI in the highest tertile were 0.33 (0.13, 0.79) for zinc, 3.56 (1.42, 8.94) for copper, and 0.37 (0.15, 0.93) for the Zn/Cu ratio. Plasma Aβ40 levels were significantly lower (P = 0.009) and plasma Aβ42/40 levels were significantly higher (P = 0.008) in MCI group compared with those in control group. Zinc concentration was positively associated with Aβ42. For per SD (327.71 μg/L) increase in plasma zinc levels, the percent change (95% CI) of Aβ42 were 2. 90 (0.85, 4.99).Conclusions Higher plasma zinc levels and higher Zn/Cu ratio were associated with lower odds of MCI in T2DM patients, while higher copper levels increased the risk of MCI. This study provides insights on plasma zinc, copper, and Zn/Cu ratio and Aβ of MCI, further studies are needed to clarify the underlying mechanisms for novel therapies that could prevent or cure multiple T2DM-related cognitive impairments.

    Keywords: type 2 diabetes mellitus, Zinc, Copper, Mild Cognitive Impairment, case-control study

    Received: 21 Nov 2024; Accepted: 27 Feb 2025.

    Copyright: © 2025 Jiao, Zhang, Duan, Cheng, Yang, Peng, Li, Xu, Chen, Chen, Liu and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yanchao Liu, Huazhong University of Science and Technology, Wuhan, China
    Hong Yan, Huazhong University of Science and Technology, Wuhan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more